RBC Cancer Research Results

RBC, Red Blood Cells: Click to Expand ⟱
Source:
Type:

Red Blood Cells



Scientific Papers found: Click to Expand⟱
7133- Ge-132,    Organogermanium, Ge-132, promotes the clearance of senescent red blood cells via macrophage-mediated phagocyte activation
- in-vitro, Nor, RAW264.7
*RBC↑, *antiOx↑,
7643- Ins,  IP6,    Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical stud
- Trial, BC, NA
RBC↑, QoL↑, eff↑, Imm↑, ChemoSen↑, chemoP↑, Dose↝,
7640- IP6,  Ins,    Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy
- Trial, BC, NA
*antiOx↑, QoL↑, RBC↑, HemoG↑, WBC↑, chemoP↑, Dose↝,
8129- LF,    Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy
- Trial, CRC, NA
Dose↝, toxicity↓, INF-γ↝, other↑, *ROS↓, Imm↑, WBC↑, Neut↑, T-Cell↑, *antiOx↑, *GSH↑, *chemoP↑, *RenoP↑, *hepatoP↑, BUN↓, creat↓, ALAT↓, AST↓, RBC↑, PC↑, Mucositis↓, *AntiBio↑, *AntiViral↑, *AntiFungal↑, *Inflam↓,
8135- LF,    Lactoferrin-A Regulator of Iron Homeostasis and Its Implications in Cancer
- Review, Var, NA - Review, AD, NA
IronCh↑, ROS↓, Imm↑, Inflam↓, *BBB↑, Iron↝, *Fenton↓, *ROS↓, *TAC↑, *SOD↑, *GPx↑, *GSH↑, *TBARS↓, *PTEN↓, *tau↓, *MAPK↓, *Aβ42↓, *Apoptosis↓, *Casp3↓, *Akt↑, *GutMicro↑, *Sepsis↓, *anemia↓, *IL6↓, *FPN↑, *TfR1/CD71↑, *Ferritin↓, *HemoG↑, *RBC↑, *eff↑, *BioAv↓, *BioAv↑, *BioAv↝, *ChemoSen↑, *BioAv↑, Ferroptosis↑,

Showing Research Papers: 1 to 5 of 5

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0)

Mucositis↓, 1,   PC↑, 1,   RBC↑, 3,   WBC↑, 2,  

Redox & Oxidative Stress(tgid=1)

Ferroptosis↑, 1,   Iron↝, 1,   ROS↓, 1,  

Metal & Cofactor Biology(tgid=2)

IronCh↑, 1,  

Core Metabolism/Glycolysis(tgid=4)

ALAT↓, 1,   BUN↓, 1,  

Cell Death(tgid=5)

Ferroptosis↑, 1,  

Transcription & Epigenetics(tgid=7)

other↑, 1,  

Immune & Inflammatory Signaling(tgid=16)

Imm↑, 3,   INF-γ↝, 1,   Inflam↓, 1,   Neut↑, 1,   T-Cell↑, 1,  

Drug Metabolism & Resistance(tgid=21)

ChemoSen↑, 1,   Dose↝, 3,   eff↑, 1,  

Clinical Biomarkers(tgid=22)

ALAT↓, 1,   AST↓, 1,   creat↓, 1,   HemoG↑, 1,  

Functional Outcomes(tgid=23)

chemoP↑, 2,   QoL↑, 2,   toxicity↓, 1,  
Total Targets: 27

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0)

anemia↓, 1,   AntiBio↑, 1,   Aβ42↓, 1,   FPN↑, 1,   RBC↑, 2,  

Redox & Oxidative Stress(tgid=1)

antiOx↑, 3,   Fenton↓, 1,   GPx↑, 1,   GSH↑, 2,   ROS↓, 2,   SOD↑, 1,   TAC↑, 1,   TBARS↓, 1,  

Metal & Cofactor Biology(tgid=2)

Ferritin↓, 1,   TfR1/CD71↑, 1,  

Cell Death(tgid=5)

Akt↑, 1,   Apoptosis↓, 1,   Casp3↓, 1,   MAPK↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

PTEN↓, 1,  

Barriers & Transport(tgid=15)

BBB↑, 1,  

Immune & Inflammatory Signaling(tgid=16)

IL6↓, 1,   Inflam↓, 1,  

Synaptic & Neurotransmission(tgid=18)

tau↓, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↓, 1,   BioAv↑, 2,   BioAv↝, 1,   ChemoSen↑, 1,   eff↑, 1,  

Clinical Biomarkers(tgid=22)

Ferritin↓, 1,   GutMicro↑, 1,   HemoG↑, 1,   IL6↓, 1,  

Functional Outcomes(tgid=23)

chemoP↑, 1,   hepatoP↑, 1,   RenoP↑, 1,  

Infection & Microbiome(tgid=24)

AntiFungal↑, 1,   AntiViral↑, 1,   Sepsis↓, 1,  
Total Targets: 39

Scientific Paper Hit Count for: RBC, Red Blood Cells
2 Inositol
2 IP6 (Inositol 1,2,3,4,5,6-hexakisphosphate)
2 Lactoferrin/Talactoferrin
1 Germanium Organic/Ge-132 / propagermanium (organogermanium)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1583  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page